Regulatory and Clinical Development Considerations for Chimeric Antigen Receptor (CAR) T Cells

Course Description

In this talk, Kaitlin Morrison, PhD takes you through the what you should consider when doing preclinical, manufacturing and clinical work involving Chimeric Antigen Receptor (CAR) T cells.

Learning Objectives

  • Learn about what a CAR T cell is
  • Learn about how preclinical studies differ from traditional preclinical studies in CAR T cells
  • Learn about clinical development considerations for CAR T cell products

To continue, click the button Take Course.

If you do not see the button, please ensure that you are logged in. If you are logged in and still don't see the button, please contact us at unclcn@unc.edu or (919) 445–1000.

Course summary
Available credit: 
  • 1.00 Participation
Course opens: 
07/28/2022
Course expires: 
04/27/2024
Photo of Kaitlin Morrison, PhD 

Kaitlin Morrison, PhD

Director of UNC Lineberger Sponsored Clinical Research
Assistant Professor of Medicine, Division of Hematology

UNC Lineberger Sponsored Clinical Research
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

 

Presenter Disclosure Information

The presenter has no relevant financial relationships with ineligible companies as defined by the ACCME.

 

 

The following accrediting agencies have approved this course for continuing education credits. Participants should understand that their individual participation and claiming credit must abide by the regulations set forth by their respective accrediting agency.

1.00 General Participation Credit
UNC Lineberger Cancer Network certificate of participation.

 

Available Credit

  • 1.00 Participation
Please login or register to take this course.